“Tralokinumab Significantly Reduces Work Productivity Impairment and Daily Activity Impairment in Adults With Atopic Dermatitis and Moderate-to-Severe Hand Involvement”. SKIN The Journal of Cutaneous Medicine 10, no. 2 (March 10, 2026): s726. Accessed May 2, 2026. https://skin.dermsquared.com/skin/article/view/4022.